NYSE · Healthcare
PACS Group, Inc. (PACS)
As-reported financials and recent SEC filings for PACS Group, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$5.29B
Net income
$191.5M
Net margin
3.6%
Diluted EPS
$1.22
ROE
20.1%
P/E (TTM)
27.0×
Market cap
$6.63B
Debt / equity
0.3×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2024 | FY2024 |
|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $3.11B | $2.40B |
| Gross profit | — | — | — | — |
| Operating income | $309.6M | $123.1M | $207.8M | $229.4M |
| Net income | $191.5M | $55.8M | $112.9M | $150.5M |
| Diluted EPS | $1.22 | $0.38 | $0.88 | $1.17 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →1442026-06-26
View on EDGAR →42026-06-26
View on EDGAR →1442026-06-25
View on EDGAR →1442026-06-25
View on EDGAR →42026-06-22
View on EDGAR →1442026-06-17
View on EDGAR →42026-06-17
View on EDGAR →Go deeper on PACS
Search PACS Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.